Lipitor swoons, taking Pfizer’s pharma sales down 25%

King Lipitor is dead. Long live ... what? That's the obvious question investors are asking today as Pfizer ($PFE) posted street-beating earnings on the back of cost cuts. Lipitor sales tanked 42%…
Read the full story: News